Journal of Cancer Diagnosis
Open Access

Testicular cancer, Diagnosis; Scrotal ultrasound; Tumor markers; Orchiectomy; Germ cell tumors; metastasis; Early detection; Non-invasive diagnostics; Serum biomarkers

Introduction

Testicular cancer is a relatively rare form of cancer, but it is the most common type of cancer in young men between the ages of 15 and 35. Despite its rarity, testicular cancer is highly treatable, even in more advanced stages, thanks to significant advances in diagnosis and treatment. Early diagnosis is key to improving outcomes and ensuring a high rate of survival [1]. Testicular cancer is a rare but significant malignancy that primarily affects young men, with the highest incidence occurring between the ages of 15 and 35. It accounts for approximately 1% of all cancers in males but is the most common solid tumor in young adults [2]. Despite its rarity, testicular cancer is of clinical importance due to its high curability, especially when diagnosed early. The survival rate exceeds 95%, largely attributed to advances in diagnostic modalities and treatment strategies [3]. Early detection is paramount, as delayed diagnosis can lead to metastasis, complicating treatment and significantly reducing survival rates [4].

The etiology of testicular cancer is not fully understood, though several risk factors have been identified, including a history of cryptorchidism (undescended testes), family history of testicular cancer, and certain genetic conditions such as Klinefelter syndrome [5]. The majority of testicular cancers are germ cell tumors (GCTs), which are broadly classified into seminomas and non-seminomas [6]. These subtypes differ in their clinical presentation, progression, and treatment response, making accurate diagnosis crucial for determining the appropriate therapeutic approach [7].

Diagnosis typically begins with a self-examination or physical examination by a healthcare professional, often prompted by the presence of a painless lump or swelling in the testicle [8]. Further evaluation involves scrotal ultrasound, which remains the gold standard for imaging due to its high sensitivity and specificity. Ultrasound helps differentiate between malignant and benign testicular masses, guiding the need for further diagnostic steps [9]. Alongside imaging, serum tumor markers such as alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (β-hCG), and lactate dehydrogenase (LDH) are routinely measured, as these biomarkers offer crucial information about the type and stage of the tumor [10].

This paper aims to provide an in-depth review of the diagnostic process for testicular cancer, from clinical examination and imaging to biochemical markers and histopathological evaluation. We will also explore emerging diagnostic technologies and strategies aimed at improving early detection rates, particularly in asymptomatic individuals. By enhancing our understanding of the current diagnostic landscape, we can work toward earlier interventions and better outcomes for patients affected by this potentially life-threatening disease.

Understanding testicular cancer

What is testicular cancer?

Testicular cancer occurs when malignant (cancerous) cells form in the tissues of one or both testicles, which are located inside the scrotum, beneath the penis. The testicles are responsible for producing male hormones, particularly testosterone, and sperm.

Types of testicular cancer

The two main types of testicular cancer are:

Seminomas: These are slow-growing cancers found in the testes. They usually occur in men in their 30s and 40s but can occur at any age. Seminomas respond well to radiation therapy.

Non-seminomas: These are a group of cancers that tend to grow more rapidly and include subtypes such as choriocarcinoma, embryonal carcinoma, teratoma, and yolk sac tumors. Non-seminomas are more common in younger men and are treated differently than seminomas.

Symptoms of testicular cancer

Testicular cancer often presents subtle signs that can be easy to overlook. Some men may not experience symptoms at all until the cancer has progressed to an advanced stage. However, the following symptoms can be indicative of testicular cancer:

• A lump or swelling in one testicle
• A feeling of heaviness in the scrotum
• A dull ache in the abdomen or groin
• Pain or discomfort in a testicle or the scrotum
• Sudden collection of fluid in the scrotum
• Enlargement or tenderness of the breasts (rare)
• Lower back pain, shortness of breath, chest pain, or a cough (if the cancer has spread)

It is essential to consult a doctor if any of these symptoms persist for more than two weeks.

Risk factors for testicular cancer

Several factors can increase a man's risk of developing testicular cancer. While having one or more risk factors does not guarantee that someone will get cancer, it does warrant extra vigilance.

Undescended testicle (cryptorchidism): Men with an undescended testicle (even if it was surgically corrected) have a significantly higher risk of developing testicular cancer.

Family history: If a close relative (father or brother) has had testicular cancer, the risk is higher.

Previous testicular cancer: If a man has had testicular cancer in one testicle, he has an increased risk of developing cancer in the other testicle.

Age: The majority of testicular cancer cases occur in men between the ages of 15 and 35, though it can happen at any age.

Race: Testicular cancer is more common among white men compared to African American, Asian, or Hispanic men.

Diagnostic process for testicular cancer

Self-examination

Regular self-examination is crucial for the early detection of testicular cancer. Men are encouraged to perform a monthly self-exam, particularly those with risk factors. A testicular self-exam should be done after a warm shower or bath, as heat helps relax the scrotum, making it easier to detect abnormalities.

• Stand in front of a mirror and check for any swelling or changes in size.
• Gently roll each testicle between the thumb and fingers to feel for lumps or unusual changes.
• Normal testicles may feel slightly firm, but there should be no pain or swelling.

If any abnormalities are found, seek medical attention promptly.

Medical diagnosis

When a patient presents symptoms or an abnormality is detected during a self-exam, the diagnostic process involves several steps:

Physical examination

The doctor will conduct a thorough physical exam, checking the testicles for lumps, size changes, or swelling. During the examination, the scrotum and other surrounding areas may also be checked for abnormalities.

Ultrasound

An ultrasound is the most common diagnostic tool for testicular cancer. It provides detailed images of the inside of the scrotum and testicles, allowing the doctor to distinguish between benign (non-cancerous) and malignant (cancerous) masses.

The ultrasound can help determine whether a mass is solid, which could indicate cancer, or filled with fluid, which is more likely to be a benign cyst.

Blood tests

Certain proteins and hormones, known as tumor markers, can be elevated in men with testicular cancer. These include:

• Alpha-fetoprotein (AFP)
• Human chorionic gonadotropin (HCG)
• Lactate dehydrogenase (LDH)

High levels of these tumor markers can indicate the presence of testicular cancer and help doctors assess how advanced the cancer is.

Radical inguinal orchiectomy

If testicular cancer is suspected, the next step is usually the surgical removal of the affected testicle, known as a radical inguinal orchiectomy. This is both a treatment and a diagnostic procedure, as the removed testicle is sent to a lab for further testing.

Imaging scans

To determine whether cancer has spread to other parts of the body (metastasized), imaging tests such as a CT (computed tomography) scan, MRI (magnetic resonance imaging), or chest X-ray may be performed. These scans help in staging the cancer and planning treatment.

Staging of testicular cancer

Once testicular cancer is confirmed, doctors use a staging system to describe how far the cancer has spread:

• Abnormal cells are found, but they have not spread beyond the testicle.
• Cancer is limited to the testicle.
• Cancer has spread to nearby lymph nodes in the abdomen.
• Cancer has spread to distant lymph nodes, the lungs, liver, or other organs.

The stage of cancer helps determine the treatment plan and prognosis.

The importance of early diagnosis

Early detection of testicular cancer is associated with a nearly 95% survival rate. Even when cancer has spread beyond the testicles, most patients still have a high chance of recovery with appropriate treatment. Regular self-exams and awareness of symptoms can significantly increase the likelihood of early diagnosis, leading to better outcomes.

Conclusion

Testicular cancer, though rare, is a serious condition that requires early detection for the best chance of successful treatment. Men should be proactive in monitoring their testicular health through regular self-examinations and seek medical attention for any abnormalities. The diagnostic process, which includes physical exams, ultrasounds, blood tests, and imaging scans, is highly effective at identifying and staging the disease, allowing for prompt and targeted treatment.

Thanks to advances in medicine, testicular cancer remains one of the most treatable forms of cancer, especially when caught early. Through increased awareness and education about the signs, symptoms, and diagnostic methods, men can take charge of their health and detect testicular cancer at its earliest stages.

Moving forward, continued research into novel diagnostic techniques, such as liquid biopsies and molecular imaging, will be crucial in refining the diagnostic pathway for testicular cancer. The integration of these new methods into clinical practice may further enhance early detection, reduce the need for invasive procedures, and ensure that more patients can benefit from curative therapies at earlier stages of the disease. The ongoing efforts to improve awareness and encourage self-examination are also critical components in reducing delays in diagnosis and optimizing survival rates in this highly treatable cancer.

References

1. Tomlin JL, Sturgeon C, Pead MJ, Muir P (2000) Use of the bisphosphonate drug alendronate for palliative management of osteosarcoma in two dogs. Vet Rec 147: 129-32.

Indexed at, Google Scholar, Crossref

2. Psychas V, Loukopoulos P, Polizopoulou ZS, Sofianidis G (2009) Multilobular tumour of the caudal cranium causing severe cerebral and cerebellar compression in a dog. J Vet Sci 10: 81-3.

Indexed at, Google Scholar, Crossref

3. Loukopoulos P, Thornton JR, Robinson WF (2003) Clinical and pathologic relevance of p53 index in canine osseous tumors. Veterinary Pathology 40: 237-48.

Indexed at, Google Scholar, Crossref

4. Bech-Nielsen S, Haskins ME (1978) Frequency of osteosarcoma among first-degree relatives of St Bernard dogs. J Natl Cancer Inst 60: 349-53.

Indexed at, Google Scholar, Crossref

5. Wilkins RM, Cullen JW, Odom L, Jamroz BA, Cullen PM, et al. (2003) Superior survival in treatment of primary nonmetastatic pediatric osteosarcoma of the extremity. Ann Surg Oncol 10: 498-507.

Indexed at, Google Scholar, Crossref

6. Kundu ZS (2014) Classification, imaging, biopsy and staging of osteosarcoma. Indian J Orthop 48: 238-46.

Indexed at, Google Scholar, Crossref

7. Papalas JA, Balmer NN, Wallace C, Sangüeza OP (2009) Ossifying dermatofibroma with osteoclast-like giant cells: report of a case and literature review. Am J Dermatopathol 31: 379-83?

Indexed at, Google Scholar, Crossref

8. Gelberg KH, Fitzgerald EF, Hwang SA, Dubrow R (1995) Fluoride exposure and childhood osteosarcoma: a case-control study. Am J Public Health 85: 1678-83?

Indexed at, Google Scholar, Crossref

9. Luetke A, Meyers PA, Lewis A, Juergens H (2014) Osteosarcoma treatment where do we stand a state of the art review. Cancer Treat Rev 40: 523-532.

Indexed at, Google Scholar, Crossref

10. Dhaliwal J, Sumathi VP, Grimer RJ (2009) Radiation-induced periosteal osteosarcoma (PDF). Grand Rounds 10: 13-18.

Indexed at, Google Scholar, Crossref